All In MedTech

Device Trial Radar · NCT05404477

Study of TransAeris® System for Enhanced Recovery After Surgery in France

Randomized Study of TransAeris® System for Enhanced Recovery After Surgery (ERAS) in Cardiac Surgery Patients in France at Risk of Prolonged Mechanical Ventilation

Last checked: Nov 19, 2026Latest source record: Nov 12, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

30

Actual

Start

Jun 22, 2022

Primary completion

Jul 13, 2023

Study completion Aug 17, 2023

Sponsor

Lead sponsor
Synapse BiomedicalNot on our public-company list
Sponsor type
Industry
First posted
Jun 3, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 22 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study will be conducted as a randomized trial of the TransAeris system for the prevention and treatment of ventilator-induced diaphragm dysfunction (VIDD) in patients identified prior to surgery to be at greater risk of prolonged mechanical ventilation (PMV).

Conditions

  • Ventilator-Induced Diaphragm Dysfunction

Interventions

  • TransAeris SystemDevice

    The TransAeris System includes four TransLoc® intramuscular diaphragm electrodes, the TransAeris external stimulator, and the FrictionLoc® connectors which provide the interface between the TransLoc electrodes and the TransAeris stimulator.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Serious device-related adverse eventsTime frame: 60 days after implantation
  2. Time on mechanical ventilationTime frame: 90 days after study completion

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • CHU - Nantes

    Nantes, France

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.